IPO Pipeline Accelerates as SpaceX Lockup Cliff Tests Market Absorption

The IPO market is entering a stretch that will stress-test the system’s ability to absorb new supply. Three deals priced or listed in the final week of July 2026 — a Blackstone-backed sandwich chain, a CRISPR biotech, and a crypto-born infrastructure company — add to an issuance calendar that is building toward an unprecedented lockup wall at SpaceX. Meanwhile, the dispersion trade that has suppressed index volatility is showing signs of fatigue, and market microstructure data suggests order-book depth has quietly contracted even as headline volumes surge. The question is not whether new shares will hit the market. It is whether the bid can absorb them without a repricing.

The SpaceX Lockup Cliff: 6.4 Billion Shares, Staggered Over a Year

The single largest market-structure event on the near-term horizon is the staggered expiration of SpaceX (SPCX) lockup restrictions. SpaceX went public on June 12, 2026, selling roughly 629 million shares at $135 — only about 5% of the company’s total share count. The remaining 95%, held by pre-IPO investors, employees, and early backers, sits behind a series of lockup expirations that begin on August 6, two business days after SpaceX’s first earnings report on August 4.^[1]

The scale is unlike anything the IPO market has processed before. Renaissance Capital senior strategist Matthew Kennedy noted that SpaceX has “the longest series of lock-up releases we’ve ever seen,” with expirations continuing through the first anniversary of the IPO in June 2027. Ultimately, more than 6.4 billion shares could become eligible for sale — more than ten times the IPO float.^[1]

The first wave on August 6 is followed by another expiration around August 20, when an additional 455.8 million shares unlock. Further tranches follow in September and beyond. Elon Musk’s stake is not covered by these early expirations; his shares become eligible in early June 2027, and he has stated he does not plan to sell.^[1]

SpaceX stock has already been testing the downside. After opening above $201 in its first week, shares fell below the $135 IPO price in mid-July and traded toward $111 — a loss of roughly 45% from the post-IPO peak. Morningstar analyst Nicolas Owens believes the lockup overhang is part of the story: “It’s conceivable that a good deal of the recent slump in SpaceX stock is precisely in anticipation of the dilution from the lockup.”^[1]

The index-fund channel will absorb some of this supply. As the float percentage rises, SpaceX’s float-adjusted market cap increases, and index providers (who review float quarterly) will lift the stock’s weighting. Morningstar’s Zachary Evens calculates that if the float-adjusted market cap triples, as it could by the end of September, the Nasdaq would treat SpaceX as a roughly $675 billion company — placing it between Walmart and Intel in the QQQ.^[1] But Owens does not think index buying will be sufficient: “Unless something changes the fundamental story or sentiment — like for the better — the supply from these lockups will outweigh demand even from index funds.”^[1]

Investing.com reported the total value of shares set to unlock at $123 billion, framing it as the largest lockup overhang in U.S. market history.^[2]

The IPO Pipeline: Jersey Mike’s, Scribe Therapeutics, Ionic Digital

While SpaceX dominates the supply narrative, the new-issuance calendar is also accelerating. Three deals in the final week of July illustrate the breadth of what is coming:

Jersey Mike’s Subs (NYSE: JMKE) — The Blackstone-backed sandwich chain launched its roadshow on July 20, 2026, setting terms for a $1.0 billion IPO. The deal involves 43,478,261 Class A shares priced at $21 to $25, with 68% of the offering comprised of secondary shares sold by existing stockholders. At the $23 midpoint, the deal grosses roughly $1.0 billion and implies a market cap near $7.3 billion on a fully diluted basis.^[3] The Wall Street Journal noted the valuation could push toward $8 billion at the high end of the range.^[3] Forbes calculated that existing shareholders could collect up to $742 million in proceeds.^[3] The high secondary component means the offering transfers existing stakes rather than funding growth — a structure that some market participants have flagged as favoring private equity exits over company capital formation.

Scribe Therapeutics (Nasdaq: SCTX) — The clinical-stage CRISPR biotech priced an upsized IPO on July 23, 2026, selling 8.58 million shares at $15 — the high end of its range — to raise $128.7 million.^[4] The deal was upsized from 7.15 million shares in the prospectus, and the stock opened at $25.00, a 67% first-day pop.^[4] Scribe, co-founded by CRISPR pioneer Jennifer Doudna, also entered a concurrent private placement with Sanofi.^[4] The strong reception is a signal that the biotech IPO window, which had been largely shut, is cracking open — though one deal does not make a trend.

Ionic Digital (Nasdaq: IOND) — A different structure entirely. Ionic Digital, born from the Celsius Network bankruptcy estate, is pursuing a direct listing on the Nasdaq Global Select Market under the ticker IOND, with trading set to begin July 28, 2026.^[5] Nasdaq set a reference price of $53, potentially valuing the company at $2 billion.^[5] No new shares are being issued and no capital is being raised; existing shareholders — including those who received shares through the Celsius bankruptcy distribution — can sell immediately.^[5] The company has pivoted from bitcoin mining to digital infrastructure for AI and high-performance computing, forecasting up to $195 million in 2026 revenue.^[5] The direct-listing format means there is no underwriter stabilizing the order book; price discovery will be entirely organic, which adds an extra layer of uncertainty in the opening sessions.

Market Plumbing: Volume Up, Depth Down

Underneath the headline IPO activity, the market’s plumbing is sending mixed signals.

Institutional trading volumes have surged 34% year-to-date through July 2026, with JPMorgan and Goldman Sachs data showing weekly volumes hitting $4.2 trillion.^[6] Yet order-book depth has contracted an estimated 23% since Q1 2026, signaling that higher volume is flowing through thinner books — a combination that increases execution risk and the potential for sudden price dislocations.^[6]

Dark pool volume has grown 340% since 2016, according to microstructure analysis, fragmenting price discovery across a wider array of venues.^[6] The implication is that the visible consolidated tape may understate the true depth of the market — or lack of it — at any given moment.

Meanwhile, the dispersion trade — a popular options strategy that involves selling index volatility and buying single-stock volatility — is showing signs of strain. After being described as Wall Street’s “most crowded vol strategy,”^[7] analysts at Mott Capital Management noted on July 26 that “liquidity headwinds build as dispersion trade begins to fade,” warning that the unwind of this positioning could remove a key source of index-level volatility suppression.^[6] If the dispersion trade continues to roll over, the low VIX readings that have characterized much of 2026 may not reflect the actual risk environment — they may reflect a crowded trade that has not yet unwound.

The S&P 500’s implied correlation has been pushing to two-year highs during peak earnings season,^[7] which is the opposite of what the dispersion trade requires to remain profitable. When stocks move together, the short-index-volatility leg of the trade loses money. If correlation stays elevated, the unwind could accelerate.

IPO and Lockup Calendar: Key Dates

What to Watch Next

1. SpaceX’s August 4 earnings and the August 6 lockup. The earnings print will set the fundamental narrative just 48 hours before the first wave of selling pressure becomes legal. If the report disappoints, the lockup sellers and the fundamental sellers will be aligned to the downside. If it impresses, the question becomes whether new demand can absorb the supply without the stock testing new lows.

2. Jersey Mike’s reception. A $1 billion IPO with 68% secondary supply is a test of whether the market will fund private-equity exits at a ~$7 billion valuation for a franchise sandwich chain. The deal’s performance will be read as a barometer for consumer-sector IPO appetite.

3. Ionic Digital’s opening sessions. Direct listings with no underwriter stabilization are pure price-discovery events. If IOND opens and trades wildly, it will reinforce concerns about market depth. If it opens orderly, it will be a constructive signal for the direct-listing format.

4. The dispersion trade. Watch S&P 500 implied correlation and the VIX–VIXEQ spread. If correlation stays elevated while single-stock vol premiums compress, the conditions for a dispersion unwind are in place. That would remove a key structural support for low index volatility.

5. Order-book depth metrics. The gap between surging volume and contracting depth is the quiet risk. Monitor bid-ask spreads and market-depth data on major ETFs (SPY, QQQ) for early signs of liquidity stress, particularly around the SpaceX lockup dates when index funds will be adjusting positions.

The trajectory is clear: supply is accelerating into a market where the plumbing is showing cracks. Whether those cracks widen or hold depends on whether demand — from index funds, from fundamental buyers, from the remaining dispersion trade — can keep pace. The next six weeks will be the first real test.

Sources

1. Why SpaceX’s earnings will likely be followed by a wave of stock salesmorningstar.com.au
2. SpaceX IPO lockup expiry: $123B in shares set to unlock in early August 2026 By Investing…investing.com
3. Jersey Mike's Announces Launch of Initial Public Offeringprnewswire.com
4. Scribe Therapeutics Announces Pricing of Upsized Initialglobenewswire.com
5. Ionic Digital Announces Effectiveness of Registration Statement and Expected Commencement…ionicdigital.com
6. Institutional Trading Flows July 2026: Volume Surge Masks Liquidity Fragmentation | Finve…finvexx.com
7. Single-Stock Volatility Premium (VIXEQ − VIX) & Implied Correlation — Live | thetrading.t…thetrading.tools